HIV

Women with HIV are more likely to get pregnant unintentionally.

Patients receiving same-day treatment for HIV were more likely to start antiretroviral therapy and had better viral suppression.

Paper device offers on-the-go inexpensive diagnosis of hepatitis C and HIV.

Potent broadly neutralizing antibody binds to HIV and causes a strong immune response.

Hepatitis B tends to be more aggressive in HIV patients, increasing the risk of cirrhosis, end-stage liver disease, and hepatocellular cancer.

Raltegravir may help boost adherence and help prevent vaginal HIV transmission.

Coinfection with hepatitis B virus isn't uncommon among those infected with HIV.

Broadly neutralizing antibodies were found to protect monkeys from an HIV-like virus.

Adherence to antiretroviral treatment negatively affected among patients with HIV who use drugs.

HIV continues to replicate in macrophages even without T-cells.

Study reports the second known real world data set for HCV patients coinfected with HIV treated with Sovaldi or Harvoni.

High prevalence of anti-HIV antibodies found in patients with hepatitis C and hepatitis B.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

Mother-to-child transmission risk in women with HIV not impacted by herpes simplex virus.

Current HIV criminalization laws may be unfairly biased due to assumptions about intent to transmit the virus in sexual activity.

Lower concentrations of serum zinc can cause difficulties during treatment of patients with HIV.

Top news of the day from across the health care landscape.

Research may lead to new drugs that boost the immune response to HIV.

Epigenetic changes seen in HIV-positive patients can cause biologic aging.

Epigenetic changes seen in HIV-positive patients can cause biologic aging.

Program seeks to help patients overcome fears, such as others learning about their HIV positive status.

Top news of the day from across the health care landscape.

The impact of zidovudine, nelfinavir, and lamivudine prophylaxis in treating neonatal HIV transmission.

Antepartum, intrapartum, and postpartum antiretroviral prophylaxis can drastically reduce the chance of HIV transmission.